default author photo

Junichiro Nishi

Toyama Institute of Health - Department of Research Planning

Japan

  • Toyama Institute of Health - Department of Research Planning

SCHOLARLY PAPERS

2

DOWNLOADS

155

TOTAL CITATIONS

2

Scholarly Papers (2)

Actions:
Email selected abstracts
1.

Nationwide Population-Based Surveillance of Invasive Pneumococcal Disease in Children in Japan (2014–2022): Impact of 13-Valent Pneumococcal Conjugate Vaccine and Covid-19 Pandemic

Number of pages: 40 Posted: 02 Jan 2025
Noriko Takeuchi, Bin Chang, Naruhiko Ishiwada, Yoshiaki Cho, Junichiro Nishi, Kenji Okada, Mikiya Fujieda, Megumi Oda, Akihiko Saitoh, Mitsuaki Hosoya, Nobuhisa Ishiguro, Kohei Takahashi, Yoshihito Ozawa and Shigeru Suga
affiliation not provided to SSRN, National Institute of Infectious Diseases, affiliation not provided to SSRN, Okinawa Prefectural Nanbu Medical enter & Children’s Medical Center - Department of Pediatric Infectious Diseases, Toyama Institute of Health - Department of Research Planning, affiliation not provided to SSRN, Kochi University, Okayama University, Niigata University, Fukushima Regional Center for the Japan Environmental and Children’s Study, Hokkaido University, Chiba University - Chiba University Hospital, Chiba University - Chiba University Hospital and Mie National Hospital
Downloads 85 (771,553)

Abstract:

Loading...

Invasive pneumococcal disease, serotype replacement, Japanese children, COVID-19, pneumococcal conjugate vaccine, population-based surveillance

2.

Dynamic Changes in Clinical Characteristics and Serotype Distribution of Invasive Pneumococcal Disease Among Adults in Japan After Introduction of the Pediatric 13-Valent Pneumococcal Conjugate Vaccine in 2013–2019

Number of pages: 25 Posted: 27 Nov 2021
Kosuke Tamura, Bin Chang, Reiko Shimbashi, Hiroshi Watanabe, Yoshinari Tanabe, Koji Kuronuma, Kengo Oshima, Takaya Maruyama, Jiro Fujita, Abe Shuichi, Kei Kasahara, Junichiro Nishi, Tetsuya Kubota, Yuki Kinjo, Hiroyuki Fujikura, Munehisa Fukusumi, Tomoe Shimada, Tomimasa Sunagawa, Motoi Suzuki, Yoshihiro Yamamoto, Kazunori Oishi and Adult IPD Study Group
Toyama Institute of Health - Department of Research Planning, National Institute of Infectious Diseases - Department of Bacteriology I, National Institute of Infectious Diseases, Kurume University - Department of Infection Control and Prevention, Niigata Prefectural Shibata Hospital - Department of Respiratory Medicine, Sapporo Medical University - Department of Respiratory Medicine and Allergology, Tohoku University - Department of Infection Control and Laboratory Diagnostics, Mie Prefectural Ichishi Hospital, University of the Ryukyus - Department of Infectious, Respiratory and Digestive Medicine, Yamagata Prefectural Central Hospital - Department of Infection Control and Prevention, Nara Medical University - Center for Infectious Diseases, Toyama Institute of Health - Department of Research Planning, Kochi University - Department of Respiratory Medicine and Allergology, Jikei University - Department of Bacteriology, Nara Medical University - Center for Infectious Diseases, National Institute of Infectious Diseases - Field Epidemiology Training Center, National Institute of Infectious Diseases - Field Epidemiology Training Center, National Institute of Infectious Diseases - Field Epidemiology Training Center, National Institute of Infectious Diseases - Infectious Disease Surveillance Center, Toyama Institute of Health - Department of Clinical Infectious Diseases, Toyama Institute of Health - Department of Bacteriology and affiliation not provided to SSRN
Downloads 70 (875,328)
Citation 2

Abstract:

Loading...

Invasive pneumococcal disease, adult, Serotype, Pneumococcal vaccine, Indirect effect, Vaccination coverage